WafaaEl-SadrMD

Infectious Disease • New York, NY

Physician

Join to view full profile

Are you Dr. El-Sadr?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
506 Malcolm X Blvd
Wp-522
New York, NY 10037
Phone+1 212-939-2740

Fax+1 212-939-2759

Summary

Dr. Wafaa El-Sadr, MD is an infectious disease specialist in New York, New York. She is currently licensed to practice medicine in New York. She is affiliated with NYC Health + Hospitals / Harlem.

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1980 - 1983
SUNY Downstate Health Sciences UniversityFellowship, Infectious Disease, 1979 - 1980
Icahn School of Medicine at Mount Sinai (Cabrini)Residency, Internal Medicine, 1977 - 1979
Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Internship, Internal Medicine, 1976 - 1977
Cairo University School of MedicineClass of 1975

Certifications & Licensure

NY State Medical License 1979 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2004-2014
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Elected Member Institute of Medicine, 2009
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
Completed
Phase 3
A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
Completed
Phase 3
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048
Completed
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
Completed
Not Applicable
A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides
Completed
Phase 3
The Treatment of Tuberculosis in HIV-Infected Patients
Completed
Phase 3
Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants Start of enrollment: 2002 Jan 01
Completed
Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants Start of enrollment: 2002 Jan 01
Completed
Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies Start of enrollment: 2010 Sep 01
Completed
Not Applicable
Seek, Test, and Retain. Linkages for Black HIV+, Substance-Using MSM Start of enrollment: 2011 Jul 01
Completed
Not Applicable
Enhanced Prevention in Couples: Feasibility Study #2 Start of enrollment: 2012 Sep 01
Completed
Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study Start of enrollment: 2014 Mar 01
Completed
Enhanced HIV Prevention in Couples: Feasibility Study #3 Start of enrollment: 2013 Dec 01
Completed
Enhanced HIV Prevention in Couples: Feasibility Study #1 Start of enrollment: 2011 Apr 01
Completed
Join now to see all

Publications & Presentations

PubMed

65 citations
Strengthening Health Systems for Chronic Care: Leveraging HIV Programs to Support Diabetes Services in Ethiopia and Swaziland.
Miriam Rabkin, Zenebe Melaku, Kerry Bruce, Ahmed Reja, Alison Koler
Journal of Tropical Medicine. 2012-09-27
1654 citations
CD4+ count-guided interruption of antiretroviral treatment.
Wafaa El-Sadr, Jens D Lundgren, James D. Neaton, Fred M. Gordin, Dominic Abrams
The New England Journal of Medicine. 2006-11-30
812 citations
Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study
Nina Friis-Møller, Rainer Weber, Peter Reiss, Rodolphe Thiébaut, Ole Kirk
AIDS. 2003-05-23

Press Mentions

Peer Support, Access to Gender-Affirming Hormone Therapy Can Better PrEP Engagement Among Trans WomenOctober 14th, 2024
Declining Access to COVID-19 Services Will Worsen Health DisparitiesMay 11th, 2023
Public Health Research Continues as We Reach Pandemic Year FourMarch 20th, 2023
Join now to see all